Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Priorix

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Measles-Mumps-Rubella Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.
BACKGROUND Chikungunya is an emerging arthropod-borne disease that has spread from tropical endemic areas to more temperate… Expand
  • figure 1
  • table 1
  • figure 3
  • table 3
  • table 2
Is this relevant?
2014
2014
Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
BACKGROUND In July 2006, Priorix-Tetra™, a combined measles-mumps-rubella-varicella (MMRV) vaccine, was licensed in Germany… Expand
Is this relevant?
Review
2011
Review
2011
Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.
BACKGROUND The MMRV combination vaccine, Priorix-Tetra™, is currently licensed in several European countries using a two-dose… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2010
2010
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
Children aged 11 to <24 months received 2 intranasal doses of live attenuated influenza vaccine (LAIV) or placebo, 35+/-7 days… Expand
Is this relevant?
2009
2009
Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.
Measles, mumps, and rubella are three common viral childhood diseases that can have serious complications. Active immunization… Expand
Is this relevant?
2007
2007
Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
Measles-mumps-rubella (MMR) vaccines containing the Urabe strain of mumps were withdrawn in the United Kingdom in 1992 following… Expand
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
BACKGROUND Combination vaccines against common childhood diseases are widely used, provide an improved coverage, are more… Expand
Is this relevant?
2006
2006
Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
The aim of this study was to investigate whether, the vaccine Priorix causes less immediate injection pain than MMR-II in… Expand
Is this relevant?
2004
2004
Effect of choice of measles-mumps-rubella vaccine on immediate vaccination pain in infants.
OBJECTIVE To compare acute pain response to 2 measles-mumps-rubella vaccines. DESIGN Double-blind clinical trial. SETTING… Expand
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
1999
1999
Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
OBJECTIVE To compare the reactogenicity and immunogenicity of a novel live attenuated measles-mumps-rubella vaccine, SB MMR… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE